Published on in Vol 10, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34502, first published .
Evaluation of the Efficacy of a Smoking Cessation Intervention for Cervical Cancer Survivors and Women With High-Grade Cervical Dysplasia: Protocol for a Randomized Controlled Trial

Evaluation of the Efficacy of a Smoking Cessation Intervention for Cervical Cancer Survivors and Women With High-Grade Cervical Dysplasia: Protocol for a Randomized Controlled Trial

Evaluation of the Efficacy of a Smoking Cessation Intervention for Cervical Cancer Survivors and Women With High-Grade Cervical Dysplasia: Protocol for a Randomized Controlled Trial

Sarah R Jones   1 , BA ;   Damon J Vidrine   1 , DrPH ;   David W Wetter   2 , PhD ;   Ya-Chen Tina Shih   3 , PhD ;   Steven K Sutton   4 , PhD ;   Lois M Ramondetta   5 , MD ;   Linda S Elting   3 , DrPH ;   Joan L Walker   6, 7 , MD ;   Katie M Smith   6 , MD ;   Summer G Frank-Pearce   8, 9 , PhD ;   Yisheng Li   10 , PhD ;   Vani N Simmons   1 , PhD ;   Jennifer I Vidrine   1 , PhD

1 Tobacco Research & Intervention Program, Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States

2 Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, United States

3 Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

4 Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States

5 Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

6 Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

7 Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

8 Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

9 TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

10 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Corresponding Author:

  • Jennifer I Vidrine, PhD
  • Tobacco Research & Intervention Program
  • Department of Health Outcomes and Behavior
  • Moffitt Cancer Center
  • 4115 E Fowler Avenue
  • Tampa, FL, 33617
  • United States
  • Phone: 1 813-745-8764
  • Fax: 1 813-449-8934
  • Email: jennifer.vidrine@moffitt.org